Title |
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints
|
---|---|
Published in |
BMC Musculoskeletal Disorders, July 2014
|
DOI | 10.1186/1471-2474-15-258 |
Pubmed ID | |
Authors |
Mary-Ann Fitzcharles, Peter A Ste-Marie, Daniel J Clauw, Shahin Jamal, Jacob Karsh, Sharon LeClercq, Jason J McDougall, Yoram Shir, Kam Shojania, Zach Walsh |
Abstract |
Arthritis pain is reported as one of the most common reasons for persons using medical herbal cannabis in North America. "Severe arthritis" is the condition justifying legal use of cannabis in over half of all authorizations in Canada, where cannabis remains a controlled substance. As champions for the care of persons with arthritis, rheumatologists must be knowledgeable of treatment modalities both traditional and non-traditional, used by their patients. As study of cannabinoid molecules in medicine is recent, we have examined the confidence in the knowledge of cannabinoids expressed by Canadian rheumatologists. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Bulgaria | 1 | 20% |
United States | 1 | 20% |
Germany | 1 | 20% |
Canada | 1 | 20% |
Netherlands | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Science communicators (journalists, bloggers, editors) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 2% |
United Kingdom | 1 | 1% |
Unknown | 89 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 20% |
Student > Bachelor | 13 | 14% |
Researcher | 11 | 12% |
Student > Postgraduate | 9 | 10% |
Student > Ph. D. Student | 7 | 8% |
Other | 14 | 15% |
Unknown | 20 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 26 | 28% |
Agricultural and Biological Sciences | 10 | 11% |
Psychology | 7 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
Biochemistry, Genetics and Molecular Biology | 3 | 3% |
Other | 13 | 14% |
Unknown | 29 | 32% |